Annual Operating Profit
-$107.91 M
+$9.23 M+7.88%
31 December 2023
Summary:
Foghorn Therapeutics annual operaing income is currently -$107.91 million, with the most recent change of +$9.23 million (+7.88%) on 31 December 2023. During the last 3 years, it has fallen by -$39.38 million (-57.46%). FHTX annual operating profit is now -314.24% below its all-time high of -$26.05 million, reached on 31 December 2018.FHTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$23.85 M
+$382.00 K+1.58%
30 September 2024
Summary:
Foghorn Therapeutics quarterly operating income is currently -$23.85 million, with the most recent change of +$382.00 thousand (+1.58%) on 30 September 2024. Over the past year, it has dropped by -$6.77 million (-39.64%). FHTX quarterly operating profit is now -82.08% below its all-time high of -$13.10 million, reached on 30 September 2019.FHTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$101.74 M
-$6.77 M-7.13%
30 September 2024
Summary:
Foghorn Therapeutics TTM operating income is currently -$101.74 million, with the most recent change of -$6.77 million (-7.13%) on 30 September 2024. Over the past year, it has increased by +$12.60 million (+11.02%). FHTX TTM operating profit is now -676.63% below its all-time high of -$13.10 million, reached on 30 September 2019.FHTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.9% | -39.6% | +11.0% |
| 3 y3 years | -57.5% | +9.2% | -8.9% |
| 5 y5 years | -314.2% | -82.1% | -676.6% |
FHTX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -57.5% | +7.9% | -39.6% | +28.4% | -8.9% | +18.9% |
| 5 y | 5 years | -314.2% | +7.9% | -82.1% | +28.4% | -676.6% | +18.9% |
| alltime | all time | -314.2% | +7.9% | -82.1% | +28.4% | -676.6% | +18.9% |
Foghorn Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$23.85 M(-1.6%) | -$101.74 M(+7.1%) |
| June 2024 | - | -$24.23 M(-14.0%) | -$94.97 M(-7.6%) |
| Mar 2024 | - | -$28.19 M(+10.7%) | -$102.78 M(-4.7%) |
| Dec 2023 | -$107.91 M(-7.9%) | -$25.46 M(+49.0%) | -$107.91 M(-5.6%) |
| Sept 2023 | - | -$17.08 M(-46.7%) | -$114.33 M(-8.9%) |
| June 2023 | - | -$32.05 M(-3.8%) | -$125.51 M(+2.3%) |
| Mar 2023 | - | -$33.32 M(+4.5%) | -$122.65 M(+4.7%) |
| Dec 2022 | -$117.14 M(+16.3%) | -$31.89 M(+12.8%) | -$117.14 M(+3.4%) |
| Sept 2022 | - | -$28.26 M(-3.2%) | -$113.33 M(+1.8%) |
| June 2022 | - | -$29.19 M(+5.0%) | -$111.33 M(+5.6%) |
| Mar 2022 | - | -$27.80 M(-1.0%) | -$105.41 M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$100.73 M(+47.0%) | -$28.08 M(+6.9%) | -$100.73 M(+7.8%) |
| Sept 2021 | - | -$26.26 M(+12.9%) | -$93.43 M(+9.1%) |
| June 2021 | - | -$23.26 M(+0.6%) | -$85.66 M(+9.9%) |
| Mar 2021 | - | -$23.13 M(+11.3%) | -$77.94 M(+13.7%) |
| Dec 2020 | -$68.53 M(+34.2%) | -$20.78 M(+12.4%) | -$68.53 M(+8.9%) |
| Sept 2020 | - | -$18.49 M(+19.0%) | -$62.94 M(+9.4%) |
| June 2020 | - | -$15.54 M(+13.2%) | -$57.55 M(+37.0%) |
| Mar 2020 | - | -$13.72 M(-9.6%) | -$42.01 M(+48.5%) |
| Dec 2019 | -$51.08 M(+96.1%) | -$15.19 M(+15.9%) | -$28.29 M(+115.9%) |
| Sept 2019 | - | -$13.10 M | -$13.10 M |
| Dec 2018 | -$26.05 M | - | - |
FAQ
- What is Foghorn Therapeutics annual operaing income?
- What is the all time high annual operating profit for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual operating profit year-on-year change?
- What is Foghorn Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly operating profit year-on-year change?
- What is Foghorn Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Foghorn Therapeutics?
- What is Foghorn Therapeutics TTM operating profit year-on-year change?
What is Foghorn Therapeutics annual operaing income?
The current annual operating profit of FHTX is -$107.91 M
What is the all time high annual operating profit for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual operaing income is -$26.05 M
What is Foghorn Therapeutics annual operating profit year-on-year change?
Over the past year, FHTX annual operaing income has changed by +$9.23 M (+7.88%)
What is Foghorn Therapeutics quarterly operating income?
The current quarterly operating profit of FHTX is -$23.85 M
What is the all time high quarterly operating profit for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly operating income is -$13.10 M
What is Foghorn Therapeutics quarterly operating profit year-on-year change?
Over the past year, FHTX quarterly operating income has changed by -$6.77 M (-39.64%)
What is Foghorn Therapeutics TTM operating income?
The current TTM operating profit of FHTX is -$101.74 M
What is the all time high TTM operating profit for Foghorn Therapeutics?
Foghorn Therapeutics all-time high TTM operating income is -$13.10 M
What is Foghorn Therapeutics TTM operating profit year-on-year change?
Over the past year, FHTX TTM operating income has changed by +$12.60 M (+11.02%)